Search

Spend more on basic research - that's one of the prescriptions for Europe offered by Jim Goodnight, founder and CEO of SAS, one of the world's largest privately held software companies.

Inexpensive, fun applications can make a big splash in the consumer robotics market, but investors are waiting for a new 'killer app' before putting their money on the table.

Hailed as one of the most important recent discoveries in biology, RNA interference has seen patent applications rise 3,000 per cent between 2000 and 2003.

Philips has announced the first fruit of its deal with the venture capital firm New Venture Partners to spin out companies based on research carried out in Philips’ corporate research laboratories.

So far Italy has barely registered on the roster of biotech nations. Now that is set to change as the first biotechnology champions emerge and the country goes all out to attract inward investment.

Three new centres for systems biology are to be launched with funding of £27 million from the UK’s Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council.

The Finnish developers of a virtual guitar are looking for investment to develop the technology and to bring it to public venues.

While US companies have halted research into plant-made pharmaceuticals - or even gone bust - European companies are pressing ahead

A new journal might be worth watching, if you don't mind tearing down barriers between disciplines.

A spin-out from Oxford University is looking to attract the attention of equity investors and pharmaceutical companies by focusing on the discovery and development of small molecules to treat cancer

Big money is going into Europe's nanotechnology. This one has an interesting partnership between research and industry.

Researchers are taking cues from a century-old spray drying technology to see if it could be developed to make better products for the food and pharmaceutical industries. They are now looking for investors and partnership from industry players.

The inventors of an imaging system to improve diagnosis of coronary heart disease are looking at licensing the technology – or getting venture capital to create a spin-out.

A researcher at the Academic Medical Centre in Amsterdam has developed instruments that could assist surgeons to perform keyhole surgery. The centre is now looking for investors and partnership or licensing agreements for the technology.

Cognitive science is moving rapidly from theory to research to practical applications.

The conclusion that there was nothing wrong with the specifics of the TeGenero trial in which six healthy volunteers ended up in intensive care has repercussions for the wider biotech industry.

The European biotechnology sector is back on track, according to Ernst & Young's 20th annual survey of biotechnology.

The European Union's plan to transform Europe's drug discovery industry borrows some of its style from the US - but not everything.

Europe needs more "angel" investors to finance its start-ups. A Prague conference highlights why it isn't getting them.

Things have changed in intellectual property, the biotech industry's big annual get-together in the US has been hearing from India, Malaysia and others.